Polymerase chain reaction (PCR) and antigen tests have been used extensively for screening during the severe acute respiratory syndrome coronavirus 2 pandemics. However, the real‐world sensitivity and specificity of the two testing procedures in the field have not yet been estimated without assuming that the PCR constitutes a gold standard test. We use latent class models to estimate the in situ performance of both tests using data from the Danish national registries. We find that the specificity of both tests is very high (>99.7%), while the sensitivities are 95.7% (95% confidence interval [CI]: 92.8%–98.4%) and 53.8% (95% CI: 49.8%–57.9%) for the PCR and antigen tests, respectively. These findings have implications for the use of confirmatory PCR tests following a positive antigen test result: we estimate that serial testing is counterproductive at higher prevalence levels.

Safe and effective vaccines are crucial for the control of Covid-19 and to protect individuals at higher risk of severe disease. The test-negative design is a popular option for evaluating the effectiveness of Covid-19 vaccines. However, the findings could be biased by several factors, including imperfect sensitivity and/or specificity of the test used for diagnosing the SARS-Cov-2 infection. We propose a simple Bayesian modeling approach for estimating vaccine effectiveness that is robust even when the diagnostic test is imperfect. We use simulation studies to demonstrate the robustness of our method to misclassification bias and illustrate the utility of our approach using real-world examples.

No abstract

Background Horses with non‐strangulating intestinal infarction (NSII) are often misdiagnosed with idiopathic peritonitis or acute colitis. Early diagnosis is essential to ensure early surgical intervention and improve survival. Methods Clinical and laboratory data from horses admitted to the University of Copenhagen Large Animal Teaching Hospital with NSII, idiopathic peritonitis or acute colitis between 2009 and 2018 were used for univariate comparisons and a multivariable logistic regression model for prediction of NSII. Results Two hundred and thirty‐one horses were included. A multivariable model for the prediction of NSII included gastric reflux (more than 5 L) (odds ratio [OR] 8.7; 95% confidence interval [CI] 2.1–36.2), abnormal findings palpated per rectum (intestinal dilatations/impactions [OR 4.43; 95% CI 1.43–13.38], colon displacements [OR 23.16; 95% CI 5.26–101.97] or intestinal mass [OR 179.7; 95% CI 23.5–1375.5]), white blood cell count (OR 1.2; 95% CI 1.1–1.4), packed cell volume (OR 0.9; 95% CI 0.8–0.9), age (OR 0.9; 95% CI 0.8–1.0) and heart rate (OR 1.1; 95% CI 1.0–1.1). The model had a low false positive rate (5%), but a high false negative rate (50%). Limitations Due to the retrospective nature of the study, sample collection was inconsistent, resulting in missing values. Conclusion The model had some capability in predicting NSII. However, the high risk of false negatives means that exploratory laparotomy should be considered in horses with peritonitis of unknown aetiology in areas where Strongylus vulgaris is prevalent and occurrence of idiopathic peritonitis is low.

Background Predicting non‐survival in horses with acute colitis improves early decision making. Therefore, this study aimed to determine the prognostic value of serum amyloid A (SAA) and other clinicopathological and clinical variables in adult horses with acute colitis. Methods Clinical variables, SAA and other blood biomarkers, including plasma L‐lactate (lactate), were assessed in 176 horses with acute colitis. A multivariate model for the prediction of non‐survival was constructed. Icelandic horses were analysed separately. Results Admission SAA was similar in survivors (median 548 mg/L; range 0–5453 mg/L) and non‐survivors (396 mg/L; 0–5294) (p = 0.43). A model for non‐survival included year of admission, lactate, heart rate, age and colic duration of more than 24 hours. Icelandic horses had a relative risk of 2.9 (95% confidence interval = 2.2–3.8) for acute colitis compared to other breeds. Lactate in Icelandic horses was higher than that in other breeds in both survivors (4.0 mmol/L, range 1.0–12.7 vs. 2.0, 0.7–12.5) and non‐survivors (10.0, 1.5–26 vs. 5.4, 0.8–22) (p < 0.001). Limitations The prognostic value of repeated measurements of SAA could not be assessed in this study, as 71% of the non‐surviving horses died within a day of admission. Conclusion Admission SAA did not predict non‐survival. Breed needs consideration when lactate is evaluated as a predictor for non‐survival in horses with colitis.